AstraZeneca (AZN) Picks Charles River Labs (CRL) for DMPK Safety Assessment Work
Go back to AstraZeneca (AZN) Picks Charles River Labs (CRL) for DMPK Safety Assessment Work| ASTRAZENECA PLC (NASDAQ: AZN) | Delayed: 92.77 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $92.77 | 52 Week High | $35.04 | |||
| Open | $92.77 | 52 Week Low | $26.97 | |||
| Day High | $92.77 | P/E | N/A | |||
| Day Low | $92.77 | EPS | $0.00 | |||
| Volume | 3,179,566 | |||||
| CHARLES RIVER LABORATORIE (NYSE: CRL) | Delayed: 295.19 +3.74 (1.28%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $291.45 | 52 Week High | $89.18 | |||
| Open | $291.78 | 52 Week Low | $65.70 | |||
| Day High | $298.18 | P/E | 137.30 | |||
| Day Low | $289.07 | EPS | $2.15 | |||
| Volume | 887,532 | |||||
